Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment

BİR YÜCEL K., SÜTCÜOĞLU O., YAZICI O., YILDIZ Y., ŞENOL E., ÜNER A.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.29, no.3, pp.760-763, 2023 (SCI-Expanded) identifier identifier identifier

Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients

Yücel K. B., Özay Z. I., SÜTCÜOĞLU O., YAZICI O., ÜNER A., GÜNEL N., et al.
Supportive Care in Cancer, vol.31, no.2, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

ROAR trial: which treatment is effective after progression?

SÜTCÜOĞLU O., Yücel K., ÜNER A., YAZICI O., ÖZDEMİR N.
LANCET ONCOLOGY, vol.23, no.3, 2022 (SCI-Expanded) identifier identifier identifier identifier

Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2

ÜNSAL O., YAZICI O., ÖZDEMİR N., ÇUBUKÇU E., OCAK B., ÜNER A., et al.
FUTURE ONCOLOGY, vol.18, no.5, pp.533-541, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies

Cavusoglu C., TAHTACI G., Dogrul R. T., Ileri I., Yildirim F., Candemir B., et al.
BMC GERIATRICS, vol.21, no.1, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

Respiratory-gated FDG PET/MRI in Evaluation of Primary Gastric Lesions and Gastric Lymph Nodes in Patients with Gastric Cancer

Ates S. G., AYDOS U., AKDEMİR Ü. Ö., YÜKSEL O., ÜNER A., DURSUN A., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.48, no.SUPPL 1, 2021 (SCI-Expanded) Sustainable Development identifier

Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib

ÇETİN B., IŞIK GÖNÜL İ., GÜMÜŞAY Ö., AFŞAR B., Bilgetekin I., ÖZET A., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.17, no.2, pp.408-413, 2021 (SCI-Expanded) identifier identifier identifier

Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme

Cetin B., IŞIK GÖNÜL İ., GÜMÜŞAY Ö., Bilgetekin I., Algin E., ÖZET A., et al.
NEUROPATHOLOGY, vol.38, no.5, pp.457-462, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

Ewing's sarcoma of kidney in a 60-year-old patient with local recurrence: A rare occurrence

Bilgetekin I., Karaca M., IŞIK GÖNÜL İ., ÜNER A., Sahinli H., Demir H., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, no.6, pp.1422-1424, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model

Cetin B., Yilmaz G. E., Armagan B., Afşar B., Demirci U., Gülbahar Ö., et al.
CHEMOTHERAPY, vol.63, no.1, pp.39-45, 2018 (SCI-Expanded) identifier identifier identifier

Crizotinib-induced toxicity in an experimental rat model

Gümüşay Ö., Esendagli-Yilmaz G., Üner A., Çetin B., Buyukberber S., Benekli M., et al.
WIENER KLINISCHE WOCHENSCHRIFT, vol.128, pp.435-441, 2016 (SCI-Expanded) identifier identifier identifier

Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients

GÜMÜŞAY Ö., Cetin B., Benekli M., Gurcan G., İLHAN M. N., Bostankolu B., et al.
JOURNAL OF CANCER EDUCATION, vol.31, no.2, pp.308-313, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

Baykara M., Benekli M., EKİNCİ Ö., Irkkan S. C., Karaca H., Demirci U., et al.
JOURNAL OF GASTROINTESTINAL SURGERY, vol.19, no.9, pp.1565-1571, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

TURAN N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.
CHINESE JOURNAL OF CANCER RESEARCH, vol.27, no.4, pp.408-416, 2015 (SCI-Expanded) Creative Commons License identifier identifier identifier

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites

Gumusay O., Benekli M., EKİNCİ Ö., Baykara M., ÖZET A., Coskun U., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, vol.45, no.5, pp.416-421, 2015 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

Factors predicting the development of distant metastases in patients with head and neck squamous cell carcinoma: A retrospective study from a single centre

Gumusay O., ÖZET A., Buyukberber S., Baykara M., Coskun U., Cetin B., et al.
JOURNAL OF BUON, vol.20, no.2, pp.521-526, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin

Algin E., ÖZET A., Gumusay O., Cetin B., AKDEMİR Ü. Ö., Benekli M., et al.
ANNALS OF NUCLEAR MEDICINE, vol.28, no.9, pp.891-896, 2014 (SCI-Expanded) identifier identifier identifier

Factors predicting recurrence in patients with grade III glial tumors: Impact of adjuvant temozolomide on recurrence

Gumusay O., Cetin B., Ozet A., Demirci U., Buyukberber S., Coskun U., et al.
JOURNAL OF BUON, vol.19, no.4, pp.1035-1040, 2014 (SCI-Expanded) identifier identifier identifier

Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer

Turan N., Benekli M., Dane F., Unal O. U., Kara H. V., Koca D., et al.
THORACIC CANCER, vol.5, no.5, pp.398-404, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

Turan N., Benekli M., Koca D., Ustaalioglu B. O., Dane F., Ozdemir N., et al.
ONCOLOGY, vol.84, no.1, pp.14-21, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

Combination of Cyclophosphamide and Carboplatin in Recurrent Malignant Gliomas

Demirci U., Buyukberber S., Ozdemir N., Coskun U., Karaca H., AKMANSU M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.23, no.3, pp.178-183, 2013 (SCI-Expanded) identifier identifier

Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer

Tonyali O., Coskun U., Sener N., İNANÇ M., Akman T., Oksuzoglu B., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.138, no.12, pp.2145-2151, 2012 (SCI-Expanded) Sustainable Development identifier identifier identifier

Hepatotoxicity associated with lapatinib in an experimental rat model

Demirci U., Buyukberber S., Yilmaz G., KEREM M., Coskun U., ÜNER A., et al.
EUROPEAN JOURNAL OF CANCER, vol.48, no.2, pp.279-285, 2012 (SCI-Expanded) identifier identifier identifier

The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer

YILDIZ R., Benekli M., Buyukberber S., Kaya A. O., Ozturk B., Yaman E., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.136, no.10, pp.1471-1476, 2010 (SCI-Expanded) Sustainable Development identifier identifier identifier

Bevacizumab Plus Irinotecan-Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens

YILDIZ R., Buyukberber S., ÜNER A., Yamac D., Coskun U., Kaya A. O., et al.
CANCER INVESTIGATION, vol.28, no.1, pp.33-37, 2010 (SCI-Expanded) Sustainable Development identifier identifier identifier

Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer

Kaya A. O., Buyukberber S., Benekli M., Coskun U., Sevinc A., AKMANSU M., et al.
MEDICAL ONCOLOGY, vol.27, no.1, pp.152-157, 2010 (SCI-Expanded) Sustainable Development identifier identifier identifier

Gemcitabine Combined With Uracil-Tegafur in Patients With Advanced Pancreatic Cancer

Coskun U., Alkis N., Celenkoglu G., Buyukberber S., ÖZKAN M., Camci C., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.101, no.8, pp.761-764, 2009 (SCI-Expanded) Sustainable Development identifier identifier identifier

Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas

Yaman E., Buyukberber S., ÜNER A., Coskun U., Yamac D., Ozturk B., et al.
TUMORI J, vol.94, no.5, pp.674-680, 2008 (SCI-Expanded) identifier identifier identifier

Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer

Acar A., Onan A., Coskun U., ÜNER A., BAĞRIAÇIK E. Ü., Atalay F., et al.
MEDICAL ONCOLOGY, vol.25, no.3, pp.279-283, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane plus platinum regimens

Coskun U., Kaya A. O., Buyukberber S., Benekli M., ÜNER A., Dikilitas M., et al.
MEDICAL ONCOLOGY, vol.25, no.2, pp.133-136, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.

Unsal D., AKYÜREK N., ÜNER A., Erpolat P., Han U., AKMANSU M., et al.
American journal of clinical oncology, vol.31, no.1, pp.55-63, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

Synchronize primary breast osteosarcoma and contralateral benign cystosarcoma phylloides: Radiologic and pathologic imaging

ÜNER A., Ozturk B., Benekli M., Coskun U., Kocak S., Kaya A. O., et al.
BREAST JOURNAL, vol.14, no.1, pp.109-110, 2008 (SCI-Expanded) identifier identifier identifier

The role of 18F-FDG PET/CT in follow up of advanced stage breast cancer

Can N., Kapucu O., ÜNER A., ÜNLÜ M.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.18, no.1, pp.9-15, 2008 (SCI-Expanded) Sustainable Development identifier identifier

Temozolomide in newly diagnosed malignant gliomas: Administered concomitantly with radiotherapy, and thereafter as consolidation treatment

Yaman E., Buyukberber S., ÜNER A., Coskun U., AKMANSU M., Benekli M., et al.
ONKOLOGIE, vol.31, no.6, pp.309-313, 2008 (SCI-Expanded) identifier identifier identifier

Whole Body 18F-FDG PET/CT Imaging in the Detection of Primary Tumours in Patients with a Metastatic Carcinoma of Unknown Origin

Kaya A. O., Coskun U., ÜNLÜ M., AKDEMİR Ü. Ö., ÖZDEMİR N., Zengin N., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.9, no.4, pp.683-686, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

Synchronous squamous cell lung carcinoma and rectum adenocarcinoma: Case report

Kaya A. O., YILDIZ R., Oeztuerk B., Yaman E., Barit G., Coskun U., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.18, no.1, pp.42-45, 2008 (SCI-Expanded) Sustainable Development identifier identifier

Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes

Benekli M., YILDIZ R., ÜNER A., Er O., Yamac D., Alkis N., et al.
ONCOLOGY, vol.72, pp.308-313, 2007 (SCI-Expanded) Sustainable Development identifier identifier identifier

A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study

Yalcin B., ÜNER A., AKBULUT H., İÇLİ F., Buyukcelik A., Isikdogan A., et al.
ANNALS OF ONCOLOGY, vol.15, pp.42, 2004 (SCI-Expanded) Sustainable Development identifier

Expression of Vascular Endothelial Growth Factor c-erbB-2 and c-erbB-3 in colorectal tumors

ÜNER A., Ebinc F. A., AKYÜREK N., Unsal D., Mentes B. B., DURSUN A.
ANNALS OF ONCOLOGY, vol.15, pp.74, 2004 (SCI-Expanded) identifier

Hematoloji-Onkoloji literatüründen seçmeler.

KILIÇ D., ÜNER A.
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol.5, no.4, pp.228-233, 2003 (SCI-Expanded)

Kolorektal kanser aşıları.

BAĞRIAÇIK E. Ü., ÜNER A.
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol.5, no.4, pp.207-214, 2003 (SCI-Expanded) Sustainable Development

Akciğer kanserlerinde moleküler onkolojik hedefe yöneltilmiş tedaviler. Solunum.

ÜNER A.
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol.1, no.5, pp.167-173, 2003 (SCI-Expanded) Sustainable Development

Metastatik kolorektal kanserde kemoterapi.

ÜNER A.
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol.5, no.4, pp.201-206, 2003 (SCI-Expanded) Sustainable Development

Erken Evre Meme Kanserinde Tedavi. Adjuvan Radyoterapi Zamanlaması: Kemoterapi Sonrası Yapılabilir.

ÜNER A.
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol.3, no.2, pp.96-98, 2001 (SCI-Expanded) Sustainable Development

İleri evre akciğer kanserlerinde palyatif kemoterapi. Solunum.

ÜNER A.
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol.2, no.3, pp.194-200, 2001 (SCI-Expanded) Sustainable Development

Vinorelbin.

ÜNER A.
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol.2, no.1, pp.60-64, 2000 (SCI-Expanded)

Articles Published in Other Journals

Association of Immunoscore, CD73 Expression and 53BP1 Expression with Neoadjuvant Chemoradiotherapy Efficacy in Patients with Locally Advanced Rectal Cancer

SÜTCÜOĞLU O., İNAN M. A., ÜNER A., SAVAŞ G., BORA H., ÖZET A., et al.
Journal of oncological sciences, vol.9, no.1, 2023 (Scopus) identifier identifier

Expression of CD10, BCL-6 and MUM-1 Markers and Their Effects on Prognosis in Diffuse Large B Cell Lymphoma

YOZGAT A., KASAPOĞLU B., AKYÜREK N., ÜNER A.
ACTA ONCOLOGICA TURCICA, vol.54, no.2, pp.189-197, 2021 (Peer-Reviewed Journal) Creative Commons License identifier

Prognostic Value of Mean Platelet Volume in Glioblastoma Multiforme

TAHTACI G., GÜNEL N., ÜNER A., TAHTACI M.
GAZI MEDICAL JOURNAL, vol.29, no.4, pp.336-339, 2018 (ESCI) Creative Commons License identifier identifier

The assessment of incidental thyroid lesions on 18F-fluorodeoxyglucose positron emission tomography/computed tomogrophy: A single centre experience

ALGIN E., ÜNER A., AKDEMİR Ü. Ö., GÜMÜŞAY Ö., KAPUCU Ö., ÖZET A.
Journal of Oncological Sciences, vol.3, no.2, pp.57-61, 2017 (Peer-Reviewed Journal)

Kolorektal kanserlerin tedavi sonuçları: tek merkezli, 200 vakalık seri

Menteş B. B., Ege B., ÜNER A., Ünsal D., YÜKSEL O., BOSTANCI H., et al.
Gazi Medical Journal, vol.18, no.3, pp.97-103, 2007 (Scopus) Sustainable Development

Aggressive tricholemmal carcinoma of the axilla

Demirtaş Y., Findikçioǧlu F., AYHAN M. S., ÖZMEN S., ÜNER A., Şimşek A., et al.
Gazi Medical Journal, vol.16, no.1, pp.51-53, 2005 (Scopus) identifier identifier

Pankreas kanserinde radyoterapinin rolü: Retrospektif değerlendirme

UNSAL D., AKMANSU M., BORA H., ÜNER A., ERPOLAT Ö. P., PAK Y.
Turkiye Klinikleri Tip Bilimleri Dergisi, 2004 (Peer-Reviewed Journal) Sustainable Development

THE ROLE OF RADIOTHERAPY IN PANCREATIC CANCER: RETROSPECTIVE EVALUATION

KILIÇ D., AKMANSU M., BORA H., ÜNER A., ERPOLAT Ö. P., Pak Y.
Pankreas Kanserinde Radyoterapinin Rolü: Retrospektif Değerlendirme, 2004 (Peer-Reviewed Journal) Sustainable Development

Detection of metastases in the sentinel lymph nodes of primary breast cancer patients by lymphatic mapping and intraoperative gamma probe: Initial experience

KİTAPÇI M. T., MENTEŞ B., ÜNER A., ABAMOR E., DURSUN A., KAPLAN M., et al.
Turkish Journal of Cancer, vol.31, no.1, pp.27-34, 2001 (Peer-Reviewed Journal) Sustainable Development

Small cell carcinoma of the prostate: Report of two cases

Sözen S., ÜNER A., Alkibay T.
Turkish Journal of Cancer, vol.30, no.3, pp.131-134, 2000 (Scopus) Sustainable Development identifier

Small cell carcinoma of the prostate: Report of two cases

SÖZEN T. S., ÜNER A., ALKİBAY T.
Turkish Journal of Cancer, vol.30, no.3, pp.131-134, 2000 (Peer-Reviewed Journal)

A small cell lung carcinoma presenting with eaton-lambert myasthenic syndrome and acanthosis nigricans

GÜNEL N., YAMAÇ D., ÜNER A.
Turkish Journal of Cancer, vol.28, no.3, pp.130-133, 1998 (Peer-Reviewed Journal)

The use of CA15-3 and estrogen receptor in breast cancer patients with bone metastases

KARAKAN T., GÜNEL N., AKÇALI Z., ÜNER A.
GAZI MEDICAL JOURNAL, vol.9, no.4, pp.149-153, 1998 (Scopus) Sustainable Development

Tropisetron ve ondansetronun cisplatine bağlı bulantı vekusmayı önleyici etkilerinin karşıklaştırılması.

ÜNER A., GÜNEL N., YAMAÇ D.
Türk Hematoloji Onkoloji Dergisi, vol.8, no.1, pp.23-26, 1998 (Peer-Reviewed Journal)

Testis Kanseri Kemoterapisinde Yenilikler

ÜNER A.
Aktüel Tıp, vol.3, no.10, pp.545-548, 1998 (Peer-Reviewed Journal) Sustainable Development

The Effect of Neoadjuvant Chemotherapy in Gastric Cancer: Report of a Case

TEKİN E., ÖKTEMER S., TANERLİ F., ÜNER A., DURSUN A., DURMUŞ O., et al.
GAZI MEDICAL JOURNAL, vol.9, no.1, pp.44-45, 1998 (Scopus) Sustainable Development

Pyomyositis in a patient with lymphoma.

ÜNER A., ÇAKIR B., GÜNEL N., AKÇALI Z., YILMAZ M.
Türk Hematoloji Onkoloji Dergisi, vol.7, no.3, pp.169-171, 1997 (Peer-Reviewed Journal)

Malign mide ülserlerinin ayırıcı tanısında ülser çevresi dokunun histopatolojik özellikleri ve CA 19-9

DUMLU G. Ş., CİNDORUK M., ÜNAL S., DOĞAN Ü. B., GÖRGÜL A., ÜNER A., et al.
Turkish Journal Of Gastroenterology, vol.8, no.2, pp.197-200, 1997 (Scopus)

Retroperitoneal liposarkom olgusu.

TAŞÇI Y., ÜNER A., ÜNER Ç., AKYAR G.
klinik Bilimler Dahiliye, vol.2, no.5, pp.110-112, 1996 (Peer-Reviewed Journal)

Primer adrenal lenfoması

SEZGİN O., ÜNER A., KARAOĞUZ H.
Klinik Bilimler: Dahiliye, vol.1, no.9, pp.244-246, 1995 (Peer-Reviewed Journal)

Periosteal osteosarkom

SAĞLIK Y., ERDEMLİ B. A., ÜNER A., DOĞAN M., MAHMUTYAZICIOĞLU K.
Türk Hematoloji Onkoloji Dergisi, vol.5, no.3, pp.152-157, 1995 (Peer-Reviewed Journal)

Results of intensified therapy in acute lymphoblastic leukemia in adults.

DİNÇOL D., İÇLİ F., ÇAY ŞENLER F., KARAOĞUZ H., DEMİRKAZIK A., ÜNER A.
Turkish Journal of Medical Research, vol.12, no.2, pp.57-61, 1994 (Peer-Reviewed Journal)

Evre II-IIIA meme kanserli premenopozal hastalarda adjuvant 6 kür CMF ve 3 kür CMF uygulamalarının karşılaştırmalı sonuçları.

DEMİRKAZIK A., İÇLİ F., SEZER M. T., KARAOĞUZ H., DİNÇOL D., GÜNEL N., et al.
Türk Hematoloji Onkoloji Dergisi, vol.3, no.3, pp.133-137, 1993 (Peer-Reviewed Journal) Sustainable Development

Yeni bir tümör belirleyicisi: TPS (Doku Polipeptid Spesifik Antijeni: TPA -M3 Epitopu)

ÜNER A., SEZER M. T.
Türkiye Klinikleri Tıp Bilimleri Dergisi, vol.13, no.2, pp.156-163, 1993 (Peer-Reviewed Journal)

Ferritin.

DEMİRKAZIK A., ÜNER A.
Türk Hematoloji Onkoloji Dergisi, vol.3, no.2, pp.110-112, 1993 (Peer-Reviewed Journal)

cisplatin based combination chemotherapy in metastatic testicular germ cell tumors

GÜNEL N., KARAOĞUZ H., İÇLİ F., DİNÇOL D., DEMİRKAZIK A., ÜNER A.
journal of ankara medical school, vol.14, no.2, pp.175-184, 1992 (Peer-Reviewed Journal)

Bir olgu nedeniyle multiple primer malign neoplazmlar

SEZGİN O., DEMİRKAZIK A., ÜNER A.
Acta Oncologica Turcica, vol.25, pp.85-90, 1992 (Peer-Reviewed Journal)

Kanser hastalarında infeksiyon ataklarının, infeksiyon düşündüren dönemlerin ve mikrobiyal kolonizasyonların değerlendirilmesi

WİLKE A., DİNÇOL D., DEMİRKAZIK A., GÜNEL N., KARAOĞUZ H., ÜNER A., et al.
Türk Hematoloji Onkoloji Dergisi, vol.2, no.3, pp.162-168, 1992 (Peer-Reviewed Journal) Sustainable Development

Diabetik nefropatinin erken tanısında mikroalbüminüri ve transferrinürinin önemi.

ÜNER A., YILMAZ N., YALÇIN S.
Ulusal Endokrinoloji Dergisi, vol.1, no.1, pp.11-16, 1991 (Peer-Reviewed Journal) Sustainable Development

Diabetik otonom nöropatiler.

MÜFTÜOĞLU O., ÜNER A., KAYSERİLİ B., PAMİR G.
Ankara Numune Hastanesi Bülteni, vol.28, pp.11-16, 1988 (Peer-Reviewed Journal) Sustainable Development

Refereed Congress / Symposium Publications in Proceedings

KASTRASYONA DİRENÇLİ PROSTAT KANSERİNDE VÜCUT KİTLE İNDEKSİNİN YENİ ANTİ-ANDROJEN TEDAVİLERİNİN TEDAVİ SONUÇLARINA ETKİSİ

Sütcüoğlu O., Yazıcı O., Özdemir N., Üner A., Özet A.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021 Sustainable Development

İLERİ EVRE PANKREAS KANSERİNDE FOLFIRİNOX BAŞARISIZLIĞI SONRASI GEMSİTABİNE BAZLI TEDAVİLERİN ETKİNLİĞİ

Sütcüoğlu O., Yılamz F., Aktürk Esen S., Erol C., Eraslan E., Üner A., et al.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021 Sustainable Development

SARKOPENİ VE OBEZİTENİN METASTATİK RCC HASTALARINDA İMMÜNOTERAPİ TEDAVİSİNİN ETKİNLİĞİNİ ÖNGÖRMEDEKİ ROLÜ,

Aslan V., Sütcüoğlu O., Ünsal O., Yazıcı O., Özdemir N., Üner A., et al.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021

TIBBİ ONKOLOJI SERVİS YATIŞ SÜRESİNİ ÖNGÖRMEDE HEMOGLOBİN, ALBÜMİN, LENFOSİT VE TROMBOSİT KOMBİNASYONUNUN DEĞERİ

Sütcüoğlu O., Ünsal O., Aslan V., Ulaş Kahya B., Tahtacı G., Özdemir N., et al.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021

RETROSPECTIVE ANALYSIS OF SORAFENIBTREATMENT IN ADVANCED-STAGEHEPATOCELLULAR CARCINOMA: A SINGLECENTER EXPERIENCE

ÜNSAL O., ASLAN V., YAZICI O., ÜNER A., ÖZET A., ÖZDEMİR N.
10.IGICC, 02 December 2020 - 06 December 2002

ONKOLOJI SERVISINDE 5HT-3 ANTAGONIST İLIŞKILIİLAÇ- İLAÇ ETKILEŞIMLERI

YURTAL Ö., FAKIOĞLU D. M., ALBAYRAK A., ÖZGER H. S., ÜNER A.
ULUSAL 23.KANSER KONGRESİ, Antalya, Turkey, 17 - 21 April 2019

ileri evre kolorektal kanserde RAS mutasyon durumu ve tümör lokalizasyonunun PET-BT 18F-FDG tutulumu ile ilişkisi

KURT İNCİ B., gürler f., YILMAZ M., TAHTACI G., YAZICI O., ÜNER A., et al.
2. ulusal immunoterapi ve onkoloji kongresi, Turkey, 31 October - 04 November 2018 Sustainable Development

A Case Study of Testicular Seminoma ExpressingSNPs and Mutations in PDGFRA, ESR1 and OtherGenes: NGS Strategies in Liquid-biopsy

BAĞRIAÇIK E. Ü., ÜNER A., ATAK YÜCEL A., TAHTACI G., GÜRLER F., YAMAN M.
IMMUNO-ONCOLOGY WORLD CONGRESS, VİYENA, Austria, 25 - 26 June 2018, pp.57

LOKAL İLERI AKCIĞER KANSERINDE TÜMÖR HÜCRELERININ PD-L1 POZITIFLIĞI, SAĞKALIM ÜZERINDE İYI PROGNOSTIK ETKISI VARDIR

KARACA M., TURAL D., AKAR E., OKAY D., ÇİL İ., AKYÜREK N., et al.
7.Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018 Sustainable Development

Lokal İleri Akciğer Kanserinde Tümör Hücrelerinin PDL1 Pozitifliği Sağkalım Üzerinde İyi Prognostik Etkisi Vardır.

KARACA M., TURAL D., okay d., AKYÜREK N., ÜNER A., ÖZET A.
7.Türk Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2018 Sustainable Development

NGS analysis for PDGFRA and ESR1 mutations in a case with testicular seminoma case.

ATAK YÜCEL A., ÜNER A., BAĞRIAÇIK E. Ü., KARAKUŞ R.
Cell-Weizmann Institute of Science, Next Gen Immunology, 11 - 14 February 2018

NGS analysis of PDGFRA ans ESR1 mutations in a case with testicular seminoma case

ATAK YÜCEL A., ÜNER A., BAĞRIAÇIK E. Ü., KARAKUŞ R., TAHTACI G., KURT İNCİ B., et al.
Cell-Weizman Institute of Science Symposium- Next Gen Immunology, Rekhovot, Israel, 11 - 14 February 2018

Gemsitabine Bağlı Ciddi Periferik Odem

AKSAN S., BİLGETEKİN İ., KARACA M., ÜNER A., ÖZET A., GÜNEL N.
22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017

Glioblastoma Multiforme Tanılı Hastalarda Notrofil/Lenfosit Oranının Prognoza Etksinin Değerlendirilmesi

DEMİR H., tufan g., GÜNAYDIN Y., ŞAHİNLİ H., KARACA M., BİLGETEKİN İ., et al.
22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017

Yaşlı Mide Kanserli Hastalarda Verilen Adjuvan Kemoterapinin Etkinliği

KARACA M., TURAL D., BİLGETEKİN İ., GÜLEÇ A., ÜNER A., ÖZET A.
22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017 Sustainable Development

D2 Disseksiyon Sonrası N3 Hastalığı Olan Mide Kanserli Hastalarda Tedavi Ne olmalıdır: Kemoterapi mi yoksa Kemoradyoterapi mi?

ÇETİN B., Bilgetekin İ., RAKICI S., Karaca F., ÖZET A., ÜNER A.
22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017, vol.1 Sustainable Development

Carcinoma of the fallopian tube presenting as axillary palpable mass

GÜLER İ., ONAN M. A., GÜNER H., HATİPOĞLU A. O., TAŞKIRAN Ç., ÜNER A.
8th International Meeting of the European Society of Gynaecological Oncology (ESGO), 19 - 22 October 2013, vol.23

Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.

İÇLİ F., AKBULUT H., DİNÇOL D., ONUR H., DEMİRKAZIK A., ÇAM R., et al.
Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, 15 July 2005 Sustainable Development

A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.

YALÇIN B., ÜNER A., AKBULUT H., İÇLİ F., IŞIKDOĞAN A., BÜYÜKÇELİK A., et al.
Proceedings of European Society of Clinical Oncology, 18 - 22 October 2002 Sustainable Development

Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group

İÇLİ F., AKBULUT H., ÜNER A., YALÇIN B., ALTINBAŞ M., BALTALI E., et al.
Proceedings of European Society of Clinical Oncology, 18 - 22 October 2002 Sustainable Development

Soluble E-Selectin Levels in Patients with Colorectal Cancer

AKÇALI Z., ÜNER A., GÜNEL N., YAMAÇ D., YILDIRIM E.
Proceedings of American Society of Clinical Oncology, 20 - 23 May 2000 Sustainable Development

Four Cycles of Adjuvant AC (Adriamycin Cyclophosphamide) ± 2 Cycles of EP (Etoposide Cisplatin) in Node Positive Patients with Breast Cancer (A Randomized Trial).

İÇLİ F., AKBULUT H., DİNÇOL D., ONUR H., DEMİRKAZIK A., ÇAM R., et al.
Proceedings of American Society of Clinical Oncology, 15 - 18 May 1999 Sustainable Development

Mutation Analysis of BRCA1 and BRCA2 in Turkish Cancer Families: a Novel Mutation BRCA2 3414del4 Found in Male Breast Cancer.

BALCI A., huusko p., paakkönen k., Launonen v., ÜNER A., EKMEKÇİ A., et al.
Proceedings of American Society of Clinical Oncology, 15 - 18 May 1999 Sustainable Development

Cisplatin Plus Vinorelbine as a Salvage Regimen in Refractory Breast Cancer.

GÜNEL N., AKÇALI Z., ÜNER A., YAMAÇ D., TÖRÜNER F. S., COŞKUN U.
Proceedings of American Society of Clinical Oncology, 15 - 18 May 1999 Sustainable Development

Serum G-CSF levels in neutropenia devoloping after chemotherapy in patients with solid tumors.

GÜNEL N., ÜNER A., NAHİDE K., YAMAÇ D., AKÇALI Z.
21st Congress of the European Society for Medical Oncology, 1 - 05 November 1996

Serum G-CSF levels in neutropenia devoloping after chemotherapy in patients with solid tumors. Monduzzi Editore (International Proceedings Division),

GÜNEL N., ÜNER A., YAMAÇ D., AKÇALI Z.
10th Mediterranean Congress of Chemotherapy, 20 - 25 October 1996

20 Yaş üzeri kadınların meme kanserine yönelik bilgi ve davranış biçimleri.

GÜNEL N., ÖZTAŞ D., ÜNER A., YAMAÇ D., ÇİFTLİK E. E.
V. Ulusal Halk Sağlığı Kongresi, Turkey, 12 - 16 October 1996 Sustainable Development

Scintimammography with Tc-99m MDP in breast cancer.

KİTAPÇI M. T., ÜNER A., ATASEVER T., İNANIR S., GÖKÇORA N., GÜNEL N., et al.
6th Asia Oceania Congress of Nuclear Medicine and Biology, 30 September - 04 October 1996 Sustainable Development

MINE-BOP in refractory or relapsed Non - Hodgkin’s lymphomas (NHL)

DİNÇOL D., İÇLİ F., ARICAN A., GÜNEL N., KARAOĞUZ H., DEMİRKAZIK A., et al.
Proceedings of American Society of Clinical Oncology, 14 - 17 May 1994

A phase II study of cisplatin (P) and DTIC for metastatic colorectal carcinoma resistant to 5- Fluorouracil (5-FU).

İÇLİ F., ÇAY ŞENLER F., DİNÇOL D., ARICAN A., KARAOĞUZ H., GÜNEL N., et al.
Proceedings of American Society of Clinical Oncology, 14 - 17 May 1994

Comparison of EAP and FAM combination chemotherapies in advanced gastric cancer

İÇLİ F., KARAOĞUZ H., DİNÇOL D., GÜNEL N., DEMİRKAZIK A., ÜNER A., et al.
Proceedings of American Society of Clinical Oncology, 16 - 18 May 1993 Sustainable Development

A phase II study of Ifosfamide in unresectable diffuse malignant mesothelioma (MM)

İÇLİ F., KARAOĞUZ H., DİNÇOL D., GÜNEL N., DEMİRKAZIK A., ÜNER A., et al.
Proceedings of American Society of Clinical Oncology, 16 - 18 May 1993

The evaluation of infectious episodes and bacterial colonization in the cancer patients

WİLKE A., DİNÇOL D., DEMİRKAZIK A., GÜNEL N., KARAOĞUZ H., ÜNER A.
5 th International Congress for Infectious Diseases, 7 - 11 June 1992 Sustainable Development

Books & Book Chapters

Mediasten tümörlerinde kemoterapi

AKÇALI Z., ÜNER A.
in: Göğüs Cerrahisi, , Editor, Göğüs Cerrahisi, pp.1341-1344, 2003

Küçük hücreli dışı akciğer kanserlerinde kemoterapi

ÜNER A.
in: Göğüs Cerrahisi, , Editor, Göğüs Cerrahisi, pp.1331-1340, 2003

Kemoterapi: Genel Prensipler

ÜNER A.
in: Jinekolojik Onkoloji, Prof. Dr. Haldun GÜNER, Editor, Çağdaş Yayıncılık–Ankara, pp.195-403, 2002

Jinekolojik kanserlerde kemoterapi ve hormonal tedavi

ÜNER A.
in: Klinik Jinekoloji, Prof. Dr. Mülazım YILDIRIM, Editor, Çağdaş Yayıncılık–Ankara, pp.483-494, 2002

Jinekolojik kanserlerde kemoterapi

ÜNER A.
in: Jinekolojik Onkoloji, Prof. Dr. Haldun GÜNER, Editor, Çağdaş Yayıncılık–Ankara, pp.405-414, 2002

İleri evre akciğer kanseri tedavisinin geleceği

ÜNER A.
in: AKCİĞER KANSERİ: Multidisipliner Yaklaşım, Prof. Dr. Atilla AKKOÇLU, Prof. Dr. Can ÖZTÜRK, Editor, Toraks Derneği Yayınları. Bilimsel tıp Yayınevi –Ankara, pp.202-206, 1999 Sustainable Development

Hodgkin hastalığı.

ÜNER A.
in: KANSER: Temel Bilgiler, Korunma, Tanı ,Tedavi., Prof. Dr. A. Can BAŞAKLAR, Editor, T.C. Sağlık Bakanlığı, Kanser Savaş Dairesi Yayınları, pp.53-61, 1998 Sustainable Development

Kemik tümörleri

ÜNER A.
in: KANSER: Temel Bilgiler, Korunma, Tanı ,Tedavi, Prof. Dr. A. Can BAŞAKLAR, Editor, T.C. Sağlık Bakanlığı, Kanser Savaş Dairesi Yayınları, pp.161-170, 1998

Hodgkin dışı lenfomalar

ÜNER A.
in: KANSER: Temel Bilgiler, Korunma, Tanı, Tedavi., Prof. Dr. A. Can BAŞAKLAR, Editor, T.C. Sağlık Bakanlığı, Kanser Savaş Dairesi Yayınları, pp.61-72, 1998 Sustainable Development

evre 3-4 küçük hücreli dışı akciğer kanserinde multimodal tedavi

ÜNER A.
in: küçük hücreli dışı akciğer kanserinde tanı ve tedavi sorunları, öztürk c., Editor, toraks derneği yayınları, pp.93-108, 1996 Sustainable Development